Issue 001
Signal Map: BCI Commercial Readiness
A clinically grounded look at invasive and non-invasive BCI companies, adoption barriers, and where reimbursement pressure may appear first.
Independent neurotechnology intelligence
Cortex Signals
Clinical signal for the people building, backing, and interpreting brain-health technology.
Evidence-first analysisCommercial readinessClinical adoption lens
Coverage
What Cortex Signals covers
Selective analysis across clinically meaningful brain and behavior technologies, with attention to evidence, adoption, regulation, and commercial readiness.
Brain-computer interfacesNeuromodulationNeurogeneticsNeurodiagnosticsCognitive assessmentSensory and neurorehabilitation devicesDigital mental health treatment devicesClinically relevant neuro-adjacent AI
Audience
Who it is for
Neurotech investors assessing clinical and commercial signal
Founders and operators building regulated brain-health tools
Commercially minded clinicians tracking innovation beyond hype
Educators, analysts, and strategic teams needing sharper context
Sample issues
Briefings built for judgment, not noise.
Issue 002
Neuromodulation Moves Beyond Pain
A briefing on psychiatric, cognitive, and neurorehabilitation use cases shaping the next generation of stimulation platforms.
Issue 003
Neurodiagnostics at the Point of Care
What portable EEG, eye-tracking, and biomarker-enabled workflows suggest about the future of brain-health screening.
Consulting & briefings
Sharper context for neurotech decisions.
Cortex Signals offers custom market scans, clinical landscape briefings, founder research support, and strategic context for investors, operators, and clinical teams.
Request a conversation
Founder
Sheena M. Lee, DMSc, PA-C
Sheena M. Lee is a clinician and educator with experience across psychiatry, neurology, intellectual and developmental disabilities, autism, and PA education. Cortex Signals reflects her interest in translating complex brain-health innovation into clinically informed, commercially useful intelligence.